XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common stock
Common stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated other comprehensive income
Accumulated other comprehensive income
Cumulative Effect, Period of Adoption, Adjusted Balance
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Cumulative Effect, Period of Adoption, Adjusted Balance
Balance, beginning of period (in shares) at Dec. 31, 2019       148,084,000 148,084,000              
Balance, beginning of year at Dec. 31, 2019 $ 4,677.0 $ (17.8) $ 4,659.2 $ 1.5 $ 1.5 $ 2,767.3 $ 2,767.3 $ 1,372.5 $ 1,372.5 $ 535.7 $ (17.8) $ 517.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 301.8                 301.8    
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense (benefit)) $ 813.6             813.6        
Common stock repurchased (in shares) (14,500,000)     (14,471,000)                
Common stock repurchased $ (263.0)     $ (0.2)   (262.8)            
Dividends on common stock (67.4)                 (67.4)    
Employee benefit plans, net of shares used to pay tax withholdings (in shares)       1,666,000                
Employee benefits plans, net of shares used to pay tax withholdings 40.0         40.0            
Balance, end of period (in shares) at Dec. 31, 2020       135,279,000                
Balance, end of year at Dec. 31, 2020 5,484.2     $ 1.3   2,544.5   2,186.1   752.3    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 441.0                 441.0    
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense (benefit)) $ (239.0)             (239.0)        
Common stock repurchased (in shares) (16,600,000)     (16,561,000)                
Common stock repurchased $ (402.4)     $ (0.1)   (402.3)            
Dividends on common stock (66.1)                 (66.1)    
Employee benefit plans, net of shares used to pay tax withholdings (in shares)       1,659,000                
Employee benefits plans, net of shares used to pay tax withholdings $ 42.0         42.0            
Balance, end of period (in shares) at Dec. 31, 2021 120,377,152     120,377,000                
Balance, end of year at Dec. 31, 2021 $ 5,259.7     $ 1.2   2,184.2   1,947.1   1,127.2    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 396.8                 396.8    
Change in unrealized appreciation (depreciation) of investments (net of applicable income tax expense (benefit)) $ (4,040.2)             (4,040.2)        
Common stock repurchased (in shares) (7,600,000)     (7,612,000)                
Common stock repurchased $ (180.0)     $ (0.1)   (179.9)            
Dividends on common stock (65.0)                 (65.0)    
Employee benefit plans, net of shares used to pay tax withholdings (in shares)       1,578,000                
Employee benefits plans, net of shares used to pay tax withholdings $ 29.5         29.5            
Balance, end of period (in shares) at Dec. 31, 2022 114,343,070     114,343,000                
Balance, end of year at Dec. 31, 2022 $ 1,400.8     $ 1.1   $ 2,033.8   $ (2,093.1)   $ 1,459.0